HEPATIC IMPAIRMENT

Clinical trials for HEPATIC IMPAIRMENT explained in plain language.

Never miss a new study

Get alerted when new HEPATIC IMPAIRMENT trials appear

Sign up with your email to follow new studies for HEPATIC IMPAIRMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 19 Not yet recruiting 8 Not yet finished but already full! 1 Completed 35 Terminated 1

Liver impairment study for cancer drug tazemetostat halted early

Knowledge-focused Terminated

This study looked at how the cancer drug tazemetostat is processed in the body of people with advanced solid tumors who also have moderate or severe liver impairment. Researchers compared drug levels in these patients to those with normal liver function. The trial was terminated …

Matched conditions: HEPATIC IMPAIRMENT

Phase: PHASE1 • Sponsor: Epizyme, Inc. • Aim: Knowledge-focused

Last updated Jun 27, 2026 12:07 UTC

HEPATIC IMPAIRMENT

Get alerted when new HEPATIC IMPAIRMENT trials appear

Liver impairment study for cancer drug tazemetostat halted early